Ocrevus and Glatiramer acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ocrevus (ocrelizumab) and Glatiramer acetate (glatiramer acetate). Common drug interactions include urinary tract infection among females and multiple sclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Ocrevus and Glatiramer acetate. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

What is Glatiramer acetate?

Glatiramer acetate has active ingredients of glatiramer acetate. eHealthMe is studying from 5,158 Glatiramer acetate users. Check the latest studies of Glatiramer acetate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

41 people who take Ocrevus and Glatiramer acetate together, and have interactions are studied.

Ocrevus and Glatiramer acetate drug interactions.

What are the common drug interactions of Ocrevus and Glatiramer Acetate, by gender? *:

female:

Urinary tract infection
Visual impairment
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Lung disorder (lung disease)
Maternal exposure before pregnancy (use of substance before pregnancy)
Headache (pain in head)
Deafness
Diarrhoea
Discomfort
Dysphagia (a condition in which swallowing is difficult or painful)

male:

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscular weakness (muscle weakness)
Arthropathy
Walking disability
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Leukocytosis (increased white blood cells)
Pneumonia
Blood immunoglobulin g decreased
Blood pressure increased
Burning sensation

What are the common drug interactions of Ocrevus and Glatiramer Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Maternal exposure during pregnancy (use of substance during pregnancy)
Premature baby
Premature rupture of membranes
Appendicitis (inflammation of the appendix)
Malignant melanoma (skin cancer rises from melancytes)
Metastases to central nervous system (cancer spreads to central nervous system)
Nausea (feeling of having an urge to vomit)
Neoplasm (tumour)

30-39:

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Drug hypersensitivity
Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

Pneumonia
Headache (pain in head)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Oropharyngeal pain
Throat irritation

50-59:

Alopecia (absence of hair from areas of the body)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Ear discomfort
Headache (pain in head)
Infection
Weight increased
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Hepatic steatosis (fatty liver disease)
Herpes zoster
Human papilloma virus test positive

60+:

Urinary tract infection
Asthenia (weakness)
Malaise (a feeling of general discomfort or uneasiness)
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Leukocytosis (increased white blood cells)
Arthropathy
Blood immunoglobulin g decreased
Blood pressure increased
Burning sensation
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 16 people, 39.02%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 29.27%
Muscle Spasms (muscle contraction): 4 people, 9.76%
Urinary Tract Infection: 3 people, 7.32%
Rickets (softening of bones): 3 people, 7.32%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 7.32%
Oral Herpes (viral infection of mouth): 3 people, 7.32%
Depression: 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Ocrevus and Glatiramer acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously